Kilitch Drugs (India) Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 306.97 million compared to INR 235.71 million a year ago. Revenue was INR 309.37 million compared to INR 237.39 million a year ago. Net income was INR 24.28 million compared to INR 21.57 million a year ago. Basic earnings per share from continuing operations was INR 1.56 compared to INR 1.39 a year ago. Diluted earnings per share from continuing operations was INR 1.56 compared to INR 1.39 a year ago.
For the six months, sales was INR 641.5 million compared to INR 431.95 million a year ago. Revenue was INR 653.61 million compared to INR 444.17 million a year ago. Net income was INR 45.14 million compared to INR 33.44 million a year ago. Basic earnings per share from continuing operations was INR 2.9 compared to INR 2.15 a year ago. Diluted earnings per share from continuing operations was INR 2.9 compared to INR 2.15 a year ago.